Skip to content
Cerebrolysin / Studies
Mixture

Cerebrolysin studies and research data

PepBank has 442 Cerebrolysin studies with results. 372 of them gave Cerebrolysin, with 1,781 results, grouped by what the studies measured. In each group, results from studies in people come first. Data as of 2026-10-30.

Searches 1,781 results and 641 papers. Newer studies from Europe PMC

Results in people
727
41% of 1,781 results
Results in animals
864
49% of 1,781 results
Results in lab cells
190
11% of 1,781 results
From computer models
0
0% of 1,781 results
The molecule

Cerebrolysin identity

Identifiers, parent molecule, targets and development stage, from curated data.

Cerebrolysin is a hydrolysate of porcine brain proteins. Product information specifies 215.2 mg concentrate per mL. A North Macedonia government medicine register lists an injectable product. The manufacturer states that Cerebrolysin is not FDA registered or approved for US distribution. This profile assigns no single receptor target to the mixture.

Kind
Mixture
Development
Approved nationally in 11 countriesEVER Neuro PharmaRegistered medicine in the cited North Macedonia government record. Not FDA approved. Source (opens in a new tab)

Targets

No molecular target is recorded for this peptide.

Sequence and structure

Residues, differences from the parent, calculated properties and 3D structure. Source values and calculated values are shown separately.

Sequence

Sequence not disclosed

Porcine brain protein hydrolysate with peptide and amino-acid components. No single sequence, chemical formula, molecular weight, SMILES or InChIKey describes the complete product. Product information states 215.2 mg concentrate per mL.

Properties

From identity sources

No formula or molecular weight is listed for Cerebrolysin.

Calculated from the sequence

No sequence is listed, so nothing can be calculated.

Net charge by pH

No charge curve

No sequence is listed for this peptide.

Composition

No sequence is listed for this peptide.

3D structure

No 3D structure

No experimental structure (PDB) and no UniProt entry for an AlphaFold model are listed for this peptide. Synthetic peptides often have neither. The sequence view above is the reference.

Results by area

What the studies measured

People first in each area, then animals, then lab cells. Counts are exact and come from studies that gave the peptide.

Trials and papers
Status and safety
Data